Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

2011 ◽  
Vol 68 (3) ◽  
pp. 249-258 ◽  
Author(s):  
Teddy Kosoglou ◽  
Larisa Reyderman ◽  
Renger G. Tiessen ◽  
André A. van Vliet ◽  
Robert R. Fales ◽  
...  
Cells ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 485
Author(s):  
Lauren A. Newman ◽  
Alia Fahmy ◽  
Michael J. Sorich ◽  
Oliver G. Best ◽  
Andrew Rowland ◽  
...  

Small extracellular vesicles (sEV) have emerged as a potential rich source of biomarkers in human blood and present the intriguing potential for a ‘liquid biopsy’ to track disease and the effectiveness of interventions. Recently, we have further demonstrated the potential for EV derived biomarkers to account for variability in drug exposure. This study sought to evaluate the variability in abundance and cargo of global and liver-specific circulating sEV, within (diurnal) and between individuals in a cohort of healthy subjects (n = 10). We present normal ranges for EV concentration and size and expression of generic EV protein markers and the liver-specific asialoglycoprotein receptor 1 (ASGR1) in samples collected in the morning and afternoon. EV abundance and cargo was generally not affected by fasting, except CD9 which exhibited a statistically significant increase (p = 0.018). Diurnal variability was observed in the expression of CD81 and ASGR1, which significantly decreased (p = 0.011) and increased (p = 0.009), respectively. These results have potential implications for study sampling protocols and normalisation of biomarker data when considering the expression of sEV derived cargo as a biomarker strategy. Specifically, the novel finding that liver-specific EVs exhibit diurnal variability in healthy subjects should have broad implications in the study of drug metabolism and development of minimally invasive biomarkers for liver disease.


2015 ◽  
Vol 11 (7S_Part_16) ◽  
pp. P740-P741 ◽  
Author(s):  
Laurent Nicolas ◽  
Klaus-Peter Kammerer ◽  
Jennifer Schaible ◽  
Jasmin Link ◽  
Oliver Kleiner ◽  
...  

2021 ◽  
Author(s):  
Erik Hartman ◽  
Simon Mahdavi ◽  
Sven Kjellstrom ◽  
Artur Schmidtchen

Finding new sustainable means of diagnosing and treating diseases is one of the most pressing issues of our time. In recent years, several endogenous peptides have been found to be both excellent biomarkers for many diseases and to possess important physiological roles which may be utilized in treatments. The detection of peptides has been facilitated by the rapid development of biological mass spectrometry and now the combination of fast and sensitive high resolution MS instruments and stable nano HP-LC equipment sequences thousands of peptides in one single experiment. In most research conducted with these advanced systems, proteolytically cleaved proteins are analyzed and the specific peptides are identified by software dedicated for protein quantification using different proteomics workflows. Analysis of endogenous peptides with peptidomics workflows also benefit from the novel sensitive and advanced instrumentation, however, the generated peptidomic data is vast and subsequently laborious to visualize and examine, creating a bottleneck in the analysis. Therefore, we have created Peptimetric, an application designed to allow researchers to investigate and discover differences between peptidomic samples. Peptimetric allows the user to dynamically and interactively investigate the proteins, peptides, and some general characteristics of multiple samples, and is available as a web application at \url{https://peptimetric.herokuapp.com}. To illustrate the utility of Peptimetric, we've applied it to a peptidomic dataset of 15 urine samples from diabetic patients and corresponding data from healthy subjects.


2015 ◽  
Vol 5 (1) ◽  
pp. 57-68 ◽  
Author(s):  
Joachim Tillner ◽  
Anne Lehmann ◽  
Tobias Paehler ◽  
Zoltan Lukacs ◽  
Sven Ruf ◽  
...  
Keyword(s):  

2013 ◽  
Vol 76 (6) ◽  
pp. 846-857 ◽  
Author(s):  
Linda E. Klumpers ◽  
Marianne Fridberg ◽  
Marieke L. de Kam ◽  
Paul B. Little ◽  
Niels Ole Jensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document